AN2 Therapeutics Inc —— 财务报表 (NASDAQ:ANTX) | MetaTrader

展开完整图表

新闻

AN2 Therapeutics Stock Cools Off After 90% Rally - AN2 Therapeutics (NASDAQ:ANTX)

AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action? - AN2 Therapeutics (NASDAQ:ANTX)

AN2 Therapeutics raises $40M in private placement

AN2 Therapeutics计划开展epetraborole治疗真性红细胞增多症的2期试验

AN2 Therapeutics plans phase 2 trial of epetraborole in PV

AN2 Therapeutics任命Sarah Williams为首席会计官

AN2 Therapeutics appoints Sarah Williams as principal accounting officer

FDA批准epetraborole治疗肺部脓肿分枝杆菌的IND申请

FDA clears IND for epetraborole trial in mycobacterium abscessus

AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?

Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?

AN2 Therapeutics (ANTX)：首席财务官Day出售价值$8883的股票